Moloney Securities Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Sell |
5,671
-135
| -2% | -$9.43K | 0.05% | 308 |
|
|
2025
Q1 | $427K | Buy |
5,806
+12
| +0.2% | +$882 | 0.06% | 279 |
|
|
2024
Q4 | $380K | Sell |
5,794
-4,504
| -44% | -$295K | 0.05% | 301 |
|
|
2024
Q3 | $802K | Sell |
10,298
-269
| -3% | -$21K | 0.11% | 217 |
|
|
2024
Q2 | $824K | Buy |
10,567
+1,325
| +14% | +$103K | 0.12% | 197 |
|
|
2024
Q1 | $626K | Buy |
9,242
+692
| +8% | +$46.9K | 0.09% | 229 |
|
|
2023
Q4 | $576K | Buy |
+8,550
| New | +$576K | 0.09% | 225 |
|
|
2017
Q4 | – | Sell |
-6,351
| Closed | -$215K | – | 273 |
|
|
2017
Q3 | $215K | Buy |
6,351
+78
| +1% | +$2.64K | 0.1% | 241 |
|
|
2017
Q2 | $214K | Sell |
6,273
-400
| -6% | -$13.6K | 0.11% | 221 |
|
|
2017
Q1 | $208K | Buy |
+6,673
| New | +$208K | 0.11% | 215 |
|